Immune Response and Inflammation
Immune Response and Inflammation is a research topic within Immunology. Science Explorer counts 76k research works in it since 1950. 21.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the recognition and signaling pathways of innate immunity, particularly through Toll-like receptors and pattern recognition receptors. It explores the role of these receptors in pathogen recognition, inflammation, antiviral responses, and the regulation of adaptive immunity. The cluster also delves into the molecular mechanisms and mediators involved in innate immune responses.
- Toll-like Receptors
- Pattern Recognition Receptors
- Inflammation
- Innate Antiviral Responses
- Cytokine-Mediated Link
- Pathogen Recognition
- NOD-Like Receptors
- Endotoxin Hyporesponsiveness
- DAMPs
- Adaptive Immunity Regulation
- Research works
- 76k fractional, since 1950
- In the world top 10%
- 16k per year above
- Top-10% rate
- 21.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -11% the tick is no change
Which countries lead Immune Response and Inflammation research?
By volume, China and the United States publish the most (2.4k and 1.4k works in 2022–2025).
By volume, 2022–2025
- 1 China 2.4k works
- 2 United States 1.4k works
- 3 Germany 313 works
- 4 Japan 307 works
- 5 India 211 works
- 6 South Korea 187 works
- 7 United Kingdom 184 works
- 8 France 171 works
- 9 Russia 158 works
- 10 Italy 133 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Immune Response and Inflammation research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Immune Response and Inflammation research, followed by Sichuan University and Sun Yat-sen University.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical College China 31 works
- 2 Sichuan University China 29 works
- 3 Sun Yat-sen University China 28 works
- 4 Harvard University United States 24 works
- 5 University of North Carolina at Chapel Hill United States 24 works
- 6 Southern Medical University China 22 works
- 7 Shanghai Jiao Tong University China 22 works
- 8 Capital Medical University China 21 works
- 9 Chinese Academy of Sciences China 20 works
- 10 Nanjing Medical University China 20 works
Who are the leading researchers in Immune Response and Inflammation?
The most-cited researchers publishing on Immune Response and Inflammation include Hermann Brenner, Bharat B. Aggarwal and Michael Karin.
- 1 Hermann Brenner 5.8k citations
- 2 Bharat B. Aggarwal 4.2k citations
- 3 Michael Karin 4k citations
- 4 Alberto Mantovani 3.6k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Immune Response and Inflammation research done?
The largest centres of Immune Response and Inflammation research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Nanjing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Wenzhou and Bethesda.
Largest cities, 2022–2025
Where it is the local speciality
- WenzhouCN · 31.8 works5.4×
- BethesdaUS · 44.5 works5.3×
Location quotient: how much more of its research is in Immune Response and Inflammation than the world average.
Where is the best place to study Immune Response and Inflammation?
Among universities, judged by research, Southern Medical University, China Medical University and Harvard University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Southern Medical University China | 60.5 | 26.5% | 9.0× | 22 | +37.6% |
| 2 | China Medical University China | 54.3 | 40.8% | 6.8× | 15 | -17.4% |
| 3 | Harvard University United States | 54.1 | 38.5% | 2.8× | 24 | -26.2% |
| 4 | Chinese Academy of Medical Sciences & Peking Union Medical College China | 53.2 | 29.7% | 4.8× | 31 | -18.3% |
| 5 | Wenzhou Medical University China | 51.0 | 28.6% | 7.3× | 17 | +7.2% |
| 6 | Zhejiang Chinese Medical University China | 50.5 | 28.7% | 8.3× | 14 | +9.9% |
| 7 | Sichuan University China | 50.1 | 33.7% | 2.5× | 29 | +7.4% |
| 8 | Capital Medical University China | 49.8 | 28.4% | 5.5× | 21 | +6.4% |
| 9 | Northeast Agricultural University China | 48.6 | 39.2% | 6.2× | 11 | +10.6% |
| 10 | Huazhong Agricultural University China | 47.5 | 22.5% | 4.9× | 11 | +238.0% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Immune Response and Inflammation research growing?
Output in 2018–2022 was 11% lower than in 2013–2017, peaking in 2013.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.